The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

NCT05862610 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Trilaciclib plus chemotherapy
DRUG: Chemotherapy

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University